ERBB2 and breast carcinoma: Therefore, we first examined the expression of four miRNAs modulated in 3D cultures in different breast tumor subtypes using RNA sequencing data from breast cancer patients (Luminal = 370, HER2 = 25, TNBC = 81) and 76 adjacent normal tissue samples published in The Cancer Genome Atlas (TCGA) database.